Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2006
Measurement of autofluorescence in the parapapillary atrophic zone in patients with ocular hypertension.
Контролируемое клиническое исследованиеСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Laemmer Robert, Horn Folkert K, Viestenz Arne, Link Barbara, Juenemann Anselm G, Mardin Christian Y
Аннотация
PURPOSE: The purpose of the study was to investigate area and intensity of parapapillary autofluorescence in patients with ocular hypertension and controls.
PATIENTS AND METHODS: Forty-two consecutive patients with ocular hypertension and 25 controls were investigated in a controlled prospective cross-sectional trial. All patients and controls were members of the Erlangen Glaucoma registry and received complete ophthalmologic examination and detailed standardized glaucoma examination, including 24-h IOP measurement, perimetrie (G1, three phases) and 15 degrees stereographic slides of the optic disc. Additionally, patients and controls were investigated with VEP with blue on yellow pattern stimulation and confocal scanning laser ophthalmoscope (HRA II, Heidelberg Engineering, Dossenheim, Germany) to detect lipofuscin in the parapapillary atrophic zone. Eyes with retinal diseases or pathologic changes of retinal pigmentepithelium were excluded. Extension of parapapillary area with increased autofluorescence compared (qualitatively) to background autofluorescence around the optic disc and the level of autofluorescence (quantitatively) in the area of qualitatively increased autofluorescence was measured. Patients and controls did not differ significantly concerning age.
RESULTS: The area of parapapillary autofluorescence was significant larger in patients with ocular hypertension than in the control group (0.21+/-0.17 mm(2) versus 0.07+/-0.06 mm(2); P<0.001, Mann-Whitney U-test). An increased latency of blue-on-yellow pattern VEP was seen in patients with OHT with increasing parapapillary autofluorescence area (r=0.496; P<0.001, Spearman-Rho test).
CONCLUSION: Parapapillary autofluorescence is increased in patients with ocular hypertension. Patients with large area of parapapillary autofluorescence had also an increased latency in blue on yellow pattern VEP.
PATIENTS AND METHODS: Forty-two consecutive patients with ocular hypertension and 25 controls were investigated in a controlled prospective cross-sectional trial. All patients and controls were members of the Erlangen Glaucoma registry and received complete ophthalmologic examination and detailed standardized glaucoma examination, including 24-h IOP measurement, perimetrie (G1, three phases) and 15 degrees stereographic slides of the optic disc. Additionally, patients and controls were investigated with VEP with blue on yellow pattern stimulation and confocal scanning laser ophthalmoscope (HRA II, Heidelberg Engineering, Dossenheim, Germany) to detect lipofuscin in the parapapillary atrophic zone. Eyes with retinal diseases or pathologic changes of retinal pigmentepithelium were excluded. Extension of parapapillary area with increased autofluorescence compared (qualitatively) to background autofluorescence around the optic disc and the level of autofluorescence (quantitatively) in the area of qualitatively increased autofluorescence was measured. Patients and controls did not differ significantly concerning age.
RESULTS: The area of parapapillary autofluorescence was significant larger in patients with ocular hypertension than in the control group (0.21+/-0.17 mm(2) versus 0.07+/-0.06 mm(2); P<0.001, Mann-Whitney U-test). An increased latency of blue-on-yellow pattern VEP was seen in patients with OHT with increasing parapapillary autofluorescence area (r=0.496; P<0.001, Spearman-Rho test).
CONCLUSION: Parapapillary autofluorescence is increased in patients with ocular hypertension. Patients with large area of parapapillary autofluorescence had also an increased latency in blue on yellow pattern VEP.